ProQR Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $3,817 | $4,519 | $4,307 | $3,843 |
Gross Profit | 3,817 | 4,519 | 4,307 | 3,843 |
EBITDA | -11,574 | -10,138 | -5,821 | -8,166 |
EBIT | -12,249 | -10,816 | -6,492 | -8,854 |
Net Income | -12,179 | -10,079 | -9,305 | -8,108 |
Net Change In Cash | 3,817 | 4,519 | 4,307 | 3,843 |
Free Cash Flow | -11,502 | -16,022 | -9,481 | -5,943 |
Cash | 119,765 | 132,414 | 149,408 | 89,401 |
Basic Shares | 105,343 | 105,296 | 81,665 | 81,665 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $18,905 | $6,514 | $4,037 | $1,354 |
Gross Profit | 18,905 | 6,380 | 1,561 | 1,354 |
EBITDA | -24,122 | -24,097 | -56,460 | -54,948 |
EBIT | -26,883 | -26,610 | -58,935 | -57,369 |
Net Income | -27,763 | -28,119 | -64,891 | -61,680 |
Net Change In Cash | 18,905 | 6,514 | 4,037 | 1,354 |
Free Cash Flow | -37,811 | 20,177 | -69,216 | -26,496 |
Cash | 149,408 | 118,925 | 94,775 | 187,524 |
Basic Shares | 81,665 | 81,011 | 71,641 | 64,182 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.12 |
2025-03-31 | -$0.11 |
2024-12-31 | -$0.09 |
